AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimilife-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Lakshya Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimilife-M1 Tablet PR

DiabetaComb-M1 tablets are a dual-action antidiabetic medication prescribed for adult patients with type 2 diabetes. This combination therapy effectively manages blood glucose levels. Always take DiabetaComb-M1 with meals, consistently at the same time daily for optimal results. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can lead to elevated blood sugar, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms (sweating, dizziness, headache, tremors) and how to treat it. Maintain regular mealtimes and carry a quick-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimilife-M1 Tablet PR

Managing Type 2 diabetes

Major Benefits of Glimilife-M1 Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Glimilife-M1 Tablet PR with a meal.

Common Side effects of Glimilife-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimilife-M1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Always take Glimilife-M1 Tablet PR with food.

How Glimilife-M1 Tablet PR works:

Glimilife-M1 Tablet PR combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimilife-M1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimilife-M1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimilife-M1 Tablet PR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimilife-M1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimilife-M1 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glimilife-M1 Tablet PR is typically initiated at a reduced dosage; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimilife-M1 Tablet PR :

Should you forget a Glimilife-M1 Tablet PR dose, administer it promptly. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glimilife-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimilife-M1 Tablet PR

Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication safely and prevent access by children, pets, and others.
Glimilife-M1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older individuals, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimilife-M1 Tablet PR and seek immediate medical attention.
Glimilife-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for treating type 1 DM.
Glimilife-M1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimilife-M1 Tablet PR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake is recommended at least annually, according to some research.
Glimilife-M1 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimilife-M1 Tablet PR and alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimilife-M1 Tablet PR
81
MRP 99
18% off